1 |
Kim DW, Yokozawa T, Hattori M, Kadota S, and Namba T. 2000. Inhibitory effects of an aqueous extract of Apocynum venetum leaves and its constituents on Cu(2+)-induced oxidative modification of low density lipoprotein. Phytother Res 14(7): 501-504.
DOI
ScienceOn
|
2 |
Steinberg, D., S. Parthasarathy, T. Carew, J. Khoo, and J. Witztum. 1989. Beyond cholesterol, modification of lowdensity lipoproteins that increase its atherogenicity. N. Engl. J. Med 320: 915-924.
DOI
ScienceOn
|
3 |
Weber C, and Erl W. 2000. Modulation of vascular cell activation, function, and apoptosis: role of antioxidants and nuclear factor kappa B. Curr Top Cell Regul 36:217-35.
|
4 |
Yla-Herttuala, S., W. Palinski, M. Rosenfield, S. Parthasarathy, T. Carew, S. Butler, J.L. Witztum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
DOI
|
5 |
Hussein O, Schlezinger S, Rosenblat M, Keidar S, and Aviram M. 1997. Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL. Atherosclerosis 128(1):11-8.
DOI
ScienceOn
|
6 |
U.P. Steinbrecher, G. Zhang, and M. Lougheed. 1990. Role of oxidatively modified LDL in atherosclerosis, Free Rad. Biol. Med 9 :155-168.
|
7 |
Jiang Y, Kusama K, and Satoh K. 2000a. Induction of cytotoxicity by chlorogenic acid in human oral tumor cell lines. Phytomedicine 7: 483-491.
DOI
ScienceOn
|
8 |
Jerome, W. G., and J. and C. Lewis. 1985. Early atherogenesis in White Carneau pigeons. II. Ultrastructural and cytochemical observations. Am. J. Pathol 119: 210-222.
|
9 |
Tanaka T, Nishikawa A, and Shima H. 1990. Inhibitory effects of chlorogenic acid, resperpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters. Basic Life Sci 52: 429-440.
|
10 |
Hoffman R., Brook J G., and Aviram M. 1992. Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies. Atherosclerosis 93(1-2):105-113.
DOI
|
11 |
M. Shaikh, S. Martini, J.R. Quiney, P. Baskerville, A.E. La Ville, N.L. Brows, R. Duffield, P.R. Turner, and B. Lewis. 1988. Modified plasma derived lipoproteins in human atherosclerosis plaques. Atherosclerosis 69: 165-172.
DOI
|
12 |
Giugliano D. 2000. Dietary antioxidants for cardiovascular prevention. Nutr Metab Cardiovasc 10(1):38-44.
|
13 |
S. Parthasarathy, and S.M. Rankin. 1992. Role of oxidized low density lipoprotein in atherogenesis. Proc. Lipid Res 31: 127-143.
DOI
ScienceOn
|
14 |
Sato K, Niki E, and Shimasaki H. 1990. Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C.Arch Biochem Biophys 279(2):402-405.
DOI
ScienceOn
|
15 |
Esterbauer H, Striegl G, Puhl H, and Rotheneder M. 1989. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 6(1): 67-75.
DOI
|
16 |
Fowler, S., P. Berberian, H. Shio, S. Goldfischer, and H. Wolinsky. 1980. Characterization of cell populations isolated from aortas of rhesus monkeys with experimental atherosclerosis. Circ. Res 46: 520-530.
DOI
ScienceOn
|
17 |
Friedman M.1999. Chemistry, biochemistry, and dietry role of potato polyphenols. J Agric Food Chem 45:1523-1540.
|
18 |
Fuhrman B and Aviram M. 2001. Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr Opin Lipidol 12(1):41-8.
DOI
ScienceOn
|
19 |
Chisolm GM and Steinberg D. 2000. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 28(12):1815-26.
DOI
ScienceOn
|
20 |
Craig WJ. 1999. Health-promoting properties of common herbs. Am J Clin Nutr 70 (3 Suppl.):491S-499S.
DOI
|
21 |
Jerome, W. G., and J. C. Lewis. 1984. Early atherogenesis in White Carneau pigeons. I. Leukocyte margination and endothelial alterations at the celiac bifurcation. Am. J. Pathol. 116: 56-68.
|
22 |
D.S. Leake. 1993. Oxidized low density lipoproteins and atherogenesis, Br. Heart J. 69: 476-478.
DOI
|
23 |
Ejzemberg R, Da Silva MH, Pinto L, and Mors WB. 1999. Action of chlorogenic acid on the complement system. An Acad BrasCienc 71: 273-277.
|
24 |
Kono Y, Kobayashi K, and Tagawa S. 1997. Antioxidant activity of polyphenolics in diets. Rate constants of reactions of chlorogenic acid and caffeic acid with reactive spieces of oxygen and nitrogen. Biochim Biophys Acta 1335: 335-342.
DOI
ScienceOn
|
25 |
Lavy A, Ben Amotz A, and Aviram M. 1993. Preferential inhibition of LDL oxidation by the all-trans isomer of beta-carotene in comparison with 9-cis beta-carotene. Eur J Clin Chem Clin Biochem 31(2):83-90.
|
26 |
Lowry OH, Rosebrough NJ, Farral AL, and Ranall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265-75.
|
27 |
Kleinveld HA, Naber AH, Stalenhoef AF, and Demacker PN. 1993. Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects. Free Radic Biol Med 15(3): 273-80.
DOI
ScienceOn
|
28 |
Jiang Y, Satoh K, and Kusama K. 2000b. Interaction between chlorogenic acid and antioxidants. Anticancer Res 20: 2473-2476.
|
29 |
J.L. Witztum, and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis, J. Clin. Invest 88: 1785-1792.
DOI
|